Skip to content
naulon

Not checkedNot checked for notices yet.

Sex dependent effects of GPR109A gene deletion in myeloid cells on bone development in mice

Perry C. Caviness, Oxana P. Lazarenko, Michael L. Blackburn and 1 more

Scientific Reports · 2025

doi:10.1038/s41598-025-12017-3 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Abstract Blueberry metabolite-derived phenolic acids are thought to suppress bone resorption via interactions with the G protein-coupled receptor 109A (GPR109A). Previously, global GPR109A knockout (GPR109A−/−) mice exhibited increased bone mass and a diminished bone-protective response to phenolic acids. While GPR109A is highly expressed in osteoclast precursor macrophages, its role in bone development remains unclear. To address this, we generated a myeloid cell-specific GPR109A knockout (GPR109Aflox/flox/LysM-Cre⁺; CKO) mouse model and assessed bone phenotypes in male and female mice at 35 days, 3 months, 6 months, and 12 months using µCT. At 35 days, CKO males showed significantly increased trabecular bone in both tibia and vertebrae when compared to control genotypes (f/f, Cre⁺). However, at later time points (6 and 12 months), Cre⁺ males exhibited similar trabecular bone phenotypes compared to CKO mice. In contrast, female CKO mice displayed significantly increased trabecular bone at 6 and 12 months. Using three-point bending analysis it was found that only 12-month-old Cre⁺ and CKO male mice exhibited altered bone mechanical properties when compared to f/f mice, while for females no significant changes in bone mechanical properties were observed. These findings suggest that GPR109A regulates bone turnover pathways in a sex-specific manner.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.